FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Claudine Bruck

Research Profile

Chemicals & Drugs

Living Beings

Procedures

Disorders

Concepts & Ideas

Molecular Sequence Data

Anatomy

Cell Line

Co-author Network

Publications

TOP 3
Valérie Vantomme; Christine Dantinne; Noreddine Amrani; Philippe Permanne; Dirk Gheysen; Claudine Bruck; Gerrit Stoter; Cedrik Michael Britten; Ulrich Keilholz; Cor H J Lamers; Marie Marchand; Marcel Delire; Maryse Guéguen
Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors.
Gerald Voss; Kelledy Manson; David Montefiori; David Ian Watkins; Jonathan Luke Heeney; Michael S Wyand; Joe Cohen; Claudine Bruck
Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine.
Sheena McCormack; A Tilzey; A Carmichael; F Gotch; J Kepple; A Newberry; G Jones; S Lister; Simon Beddows; R Cheingsong; A Rees; Abdel G Babiker; J Banatvala; Claudine Bruck; Janet Darbyshire; D Tyrrell; C Van Hoecke; Jonathan Weber
A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Claudine Bruck (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2004: Valérie Vantomme; Christine Dantinne; Noreddine Amrani; Philippe Permanne; Dirk Gheysen; Claudine Bruck; Gerrit Stoter; Cedrik Michael Britten; Ulrich Keilholz; Cor H J Lamers; Marie Marchand; Marcel Delire; Maryse Guéguen
Immunologic analysis of a phase I/II study of vaccination with MAGE-3 protein combined with the AS02B adjuvant in patients with MAGE-3-positive tumors.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2004;27(2):124-35.
2003: Gerald Voss; Kelledy Manson; David Montefiori; David Ian Watkins; Jonathan Luke Heeney; Michael S Wyand; Joe Cohen; Claudine Bruck
Prevention of disease induced by a partially heterologous AIDS virus in rhesus monkeys by using an adjuvanted multicomponent protein vaccine.
Journal of virology 2003;77(2):1049-58.
2000: Sheena McCormack; A Tilzey; A Carmichael; F Gotch; J Kepple; A Newberry; G Jones; S Lister; Simon Beddows; R Cheingsong; A Rees; Abdel G Babiker; J Banatvala; Claudine Bruck; Janet Darbyshire; D Tyrrell; C Van Hoecke; Jonathan Weber
A phase I trial in HIV negative healthy volunteers evaluating the effect of potent adjuvants on immunogenicity of a recombinant gp120W61D derived from dual tropic R5X4 HIV-1ACH320.
Vaccine 2000;18(13):1166-77.
1999: Simon Beddows; S Lister; R Cheingsong; Claudine Bruck; Jonathan Weber
Comparison of the antibody repertoire generated in healthy volunteers following immunization with a monomeric recombinant gp120 construct derived from a CCR5/CXCR4-using human immunodeficiency virus type 1 isolate with sera from naturally infected individuals.
Journal of virology 1999;73(2):1740-5.
1998: Petra Mooij; M van der Kolk; Willy M J M Bogers; Peter Ten Haaft; Peter H van der Meide; Neil Almond; J Stott; M Deschamps; D Labbe; P Momin; Gerald Voss; Paul von Hoegen; Claudine Bruck; Jonathan Luke Heeney
A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian-human immunodeficiency virus infection.
AIDS (London, England) 1998;12(5):F15-22.
1998: E Jim Stott; Neil Almond; K Kent; Kenneth Barry Walker; Robin Hull; Jane Rose; Peter Silvera; Rebecca Sangster; Terry Corcoran; Jenny Lines; K Silvera; Paul A Luciw; M Murphy-Corb; P Momin; Claudine Bruck
Evaluation of a candidate human immunodeficiency virus type 1 (HIV-1) vaccine in macaques: effect of vaccination with HIV-1 gp120 on subsequent challenge with heterologous simian immunodeficiency virus-HIV-1 chimeric virus.
The Journal of general virology 1998;79 ( Pt 3)():423-32.
1997: Jonathan Luke Heeney; Claudine Bruck; J Goudsmit; Luc Montagnier; A Schultz; D Tyrrell; Susan Zolla-Pazner
Immune correlates of protection from HIV infection and AIDS.
Immunology today 1997;18(1):4-8.
1996: S P Mossman; Françoise Bex; P Berglund; J Arthos; S P O'Neil; D Riley; D H Maul; Claudine Bruck; P Momin; Arsène Burny; P N Fultz; James I Mullins; Peter Liljeström; Edward A Hoover
Protection against lethal simian immunodeficiency virus SIVsmmPBj14 disease by a recombinant Semliki Forest virus gp160 vaccine and by a gp120 subunit vaccine.
Journal of virology 1996;70(3):1953-60.
1995: W Dalemans; A Delers; C Delmelle; F Denamur; R Meykens; C Thiriart; S Veenstra; M Francotte; Claudine Bruck; J Cohen
Protection against homologous influenza challenge by genetic immunization with SFV-RNA encoding Flu-HA.
Annals of the New York Academy of Sciences 1995;772():255-6.
1995: M Deschamps; B Lambrecht; M Horth; S Kummert; H R Gelderblom; Claudine Bruck; Arsène Burny
Genetic construction and in vitro characterization of SIVsmmPBj14-1.9 noninfectious particles.
AIDS research and human retroviruses 1995;11(7):855-61.
1995: Peter Ten Haaft; M Cornelissen; Jaap Goudsmit; W Koornstra; R Dubbes; Henk Niphuis; M Peeters; C Thiriart; Claudine Bruck; Jonathan Luke Heeney
Virus load in chimpanzees infected with human immunodeficiency virus type 1: effect of pre-exposure vaccination.
The Journal of general virology 1995;76 ( Pt 4)():1015-20.
1994: Peter Silvera; B Flanagan; K Kent; Erling Rud; C Powell; Terry Corcoran; Claudine Bruck; C Thiriart; Nancy Haigwood; E Jim Stott
Fine analysis of humoral antibody response to envelope glycoprotein of SIV in infected and vaccinated macaques.
AIDS research and human retroviruses 1994;10(10):1295-304.
1994: Claudine Bruck; C Thiriart; L Fabry; M Francotte; P Pala; O Van Opstal; J Culp; M Rosenberg; Michel Jean De Wilde; P Heidt; Jonathan Luke Heeney
HIV-1 envelope-elicited neutralizing antibody titres correlate with protection and virus load in chimpanzees.
Vaccine 1994;12(12):1141-8.
1994: Z R Israel; P F Edmonson; D H Maul; S P O'Neil; S P Mossman; C Thiriart; L Fabry; O Van Opstal; Claudine Bruck; Françoise Bex
Incomplete protection, but suppression of virus burden, elicited by subunit simian immunodeficiency virus vaccines.
Journal of virology 1994;68(3):1843-53.
1992: J P Langedijk; Nicole Back; E Kinney-Thomas; Claudine Bruck; M Francotte; Jaap Goudsmit; Rob H Meloen
Comparison and fine mapping of both high and low neutralizing monoclonal antibodies against the principal neutralization domain of HIV-1.
Archives of virology 1992;126(1-4):129-46.
1990: Nicole Back; C Thiriart; A Delers; C Ramautarsing; Claudine Bruck; Jaap Goudsmit
Association of antibodies blocking HIV-1 gp 160-sCD4 attachment with virus neutralizing activity in human sera.
Journal of medical virology 1990;31(3):200-8.
1988: C Thiriart; Jaap Goudsmit; P Schellekens; F Barin; D Zagury; Michel Jean De Wilde; Claudine Bruck
Antibodies to soluble CD4 in HIV-1-infected individuals.
AIDS (London, England) 1988;2(5):345-51.
1988: Jaap Goudsmit; C Thiriart; L Smit; Claudine Bruck; C J Gibbs
Temporal development of cross-neutralization between HTLV-III B and HTLV-III RF in experimentally infected chimpanzees.
Vaccine 1988;6(3):229-32.
1988: K Valerie; A Delers; Claudine Bruck; C Thiriart; H Rosenberg; CM Debouck; M Rosenberg
Activation of human immunodeficiency virus type 1 by DNA damage in human cells.
Nature 1988;333(6168):78-81.